---
title: Time to disability milestones and annualized relapse rates in NMOSD and MOGAD
date: '2023-12-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38086777/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231213170709&v=2.18.0
source: heidelberg[Affiliation]
description: 'OBJECTIVE: To investigate accumulation of disability in neuromyelitis
  optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein-antibody-associated
  disease (MOGAD) in a changing treatment landscape. We aimed to identify risk factors
  for the development of disability milestones in relation to disease duration, number
  of attacks, and ...'
disable_comments: true
---
OBJECTIVE: To investigate accumulation of disability in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein-antibody-associated disease (MOGAD) in a changing treatment landscape. We aimed to identify risk factors for the development of disability milestones in relation to disease duration, number of attacks, and ...